133 related articles for article (PubMed ID: 17328247)
1. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
Hong SP; Chang KS; Choi DH; Choi JS
Arch Pharm Res; 2007 Jan; 30(1):90-5. PubMed ID: 17328247
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats.
Choi JS; Han HK
Int J Pharm; 2005 Nov; 305(1-2):122-8. PubMed ID: 16226412
[TBL] [Abstract][Full Text] [Related]
3. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
Li C; Choi JS
Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
[TBL] [Abstract][Full Text] [Related]
4. Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats.
Choi HJ; Choi JS
Arch Pharm Res; 2005 Aug; 28(8):970-6. PubMed ID: 16178425
[TBL] [Abstract][Full Text] [Related]
5. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats.
Hong SP; Choi DH; Choi JS
Cardiovasc Ther; 2008; 26(4):269-75. PubMed ID: 19035878
[TBL] [Abstract][Full Text] [Related]
6. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
Choi DH; Chang KS; Hong SP; Choi JS; Han HK
Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
[TBL] [Abstract][Full Text] [Related]
7. Effects of lovastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by lovastatin.
Hong SP; Yang JS; Han JY; Ha SI; Chung JW; Koh YY; Chang KS; Choi DH
J Pharm Pharmacol; 2011 Jan; 63(1):129-35. PubMed ID: 21189658
[TBL] [Abstract][Full Text] [Related]
8. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
Cho YA; Choi DH; Choi JS
J Pharm Pharmacol; 2009 Jun; 61(6):825-9. PubMed ID: 19505375
[TBL] [Abstract][Full Text] [Related]
9. Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin.
Choi DH; Choi JS; Li C; Choi JS
Pharmacol Rep; 2011; 63(6):1574-82. PubMed ID: 22358108
[TBL] [Abstract][Full Text] [Related]
10. Repeated dosing of piperine induced gene expression of P-glycoprotein via stimulated pregnane-X-receptor activity and altered pharmacokinetics of diltiazem in rats.
Qiang F; Kang KW; Han HK
Biopharm Drug Dispos; 2012 Nov; 33(8):446-54. PubMed ID: 22927137
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats.
Choi JS; Han HK
Pharmacol Res; 2005 Nov; 52(5):386-91. PubMed ID: 16002304
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin and atorvastatin enhance hypotensive effect of diltiazem in rats.
Marumo H; Satoh K; Yamamoto A; Kaneta S; Ichihara K
Yakugaku Zasshi; 2001 Oct; 121(10):761-4. PubMed ID: 11676178
[TBL] [Abstract][Full Text] [Related]
13. The influence of cimetidine on the pharmacokinetics of diltiazem and its main metabolite in rabbits.
Choi JS; Burm JP
Arch Pharm Res; 2004 Feb; 27(2):254-8. PubMed ID: 15022730
[TBL] [Abstract][Full Text] [Related]
14. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors.
Lee CK; Choi JS; Choi DH
Pharmacol Rep; 2015 Feb; 67(1):44-51. PubMed ID: 25560574
[TBL] [Abstract][Full Text] [Related]
15. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors.
Yang SH; Choi JS; Choi DH
Pharmacology; 2011; 88(1-2):1-9. PubMed ID: 21709429
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
Schwarzwald CC; Sams RA; Bonagura JD
J Vet Pharmacol Ther; 2006 Jun; 29(3):165-71. PubMed ID: 16669860
[TBL] [Abstract][Full Text] [Related]
17. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
[TBL] [Abstract][Full Text] [Related]
18. Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil.
Choi DH; Shin WG; Choi JS
Eur J Clin Pharmacol; 2008 May; 64(5):445-9. PubMed ID: 18193210
[TBL] [Abstract][Full Text] [Related]
19. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.
Choi JS; Li X
Int J Pharm; 2005 Jun; 297(1-2):1-8. PubMed ID: 15907592
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus.
Kovarik JM; Hartmann S; Hubert M; Berthier S; Schneider W; Rosenkranz B; Rordorf C
J Clin Pharmacol; 2002 Feb; 42(2):222-8. PubMed ID: 11831546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
